Thomas Pogge, Professor of Philosophy and International Affairs at Yale University in the United States to speak out on reform with the pharmaceutical industry on July 17th in the UK with a new proposal and business model proposition called the Health Impact Fund in the interest of protecting human rights. It would be deemed to be a global agency to reward patentees of new medicines and annual payments based on the impact the drug has to global health. I’m sure there will be much to say, since this would propose uprooting the current method of practice that has been in place for years. AstraZeneca is sponsoring the lecture. BD
In his AstraZeneca-sponsored lecture entitled, 'Advanced Medicines: Must We Exclude the Global Poor?', Pogge will propose an alternative licensing system called the Health Impact Fund (HIF) which he says is "required as an add-on to the existing system to render it human-rights compliant". The HIF would be a global agency, says Pogge, underwritten by governments. It would offer to reward the patentee of any new medicine, during its first decade or so, with annual payments proportional to this medicine's demonstrated global health impact.
Drugs industry protecting 'morally unacceptable' patent system
0 comments :
Post a Comment